Acne

Journal of the Royal College of Physicians of London

Volumn 31, Issue 4, 1997, Pages 360-363

  Munro, Colin S ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; ANTIBIOTIC AGENT; RETINOID;

ACNE; HUMAN; ORAL DRUG ADMINISTRATION; SHORT SURVEY; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFANT; KERATOLYTIC AGENTS; MALE; PROGNOSIS; RETINOIDS; TREATMENT OUTCOME;

EID: 0030762844     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (23)

1. Burton JL, Cunliffe WJ, Stafford I, Shuster S. The prevalence of acne vulgaris in adolescence. Br J Dermatol 1971;85: 119-26.
2. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J 1979;278:109-10.
3. Burke BM, Cunliffe WJ. The assessment of acne vulgaris: the Leeds technique. Br J Dermatol 1984;111:83-92.
4. Motley RJ, Finlay AY. Practical use of disability index in the routine management of acne. Clin Exp Dermatol 1992;17:1-3.
5. Cunliffe WJ. Unemployment and acne. Br J Dermatol 1986;115:379-83.
6. Benhamou CL, Chamont AM, Kahn MF. Synovitis-acne-pustulosis-hyperostosisosteomyelitis syndrome (SAPHO) - a new syndrome among the spondyloarthropathies. Clin Exp Rheumatol 1988;6:109-12.
7. Leyden JJ. New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995;32:S15-S25.
8. Burton JL, Shuster S. The relationship between seborrhoea and acne vulgaris. Br J Dermatol 1971;84:600-1.
9. Webster G. Inflammation in acne vulgaris. J Am Acad Dermatol 1995; 33:247-53.
10. Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne - a twin study. Br J Dermatol 1988; 118:393-6.
11. Voorhees JJ, Wilkins JW Jr, Hayes E, Harrell ER. Nodulocystic acne as a phenotypic feature of the XYY genotype. Arch Dermatol 1972;105:913-9.
12. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet 1985;22:367-73.
13. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9:165-72.
14. Chen W, Zouboulis CC, Orfanos CE. The 5-alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology 1996;193:177-84.
15. Crow KD. Chloracne and its potential clinical implications. Clin Exp Dermatol 1981;6:243-57.
16. Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH. Lithium therapy associated with hidradenitis suppurativa: case report and review of the literature. J Am Acad Dermatol 1995; 32:382-6.
17. Fulton JE, Plewig C, Kligman AM. Effect of chocolate on acne vulgaris. JAMA 1969;210:2071-4.
18. Shalita A, Weiss JS, Chalker DK, Ellis CN, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris. J Am Acad Dermatol 1996; 34:482-5.
19. Griffiths CEM. Nicotinamide 4% gel for the treatment of inflammatory acne vulgaris. J Dermatol Treat 1995;6: S8-10.
20. Moss C, Ferner RE. Minocycline for acne. Br Med J 1996;312:138.
21. Eady EA, Jones CE, Tipper JL, Cove JH, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J 1993; 306:555-6.
22. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992;27:S2-7.
23. Cunliffe WJ, Gray JA, Macdonald-Hull, Hughes BR, et al. Cost effectiveness of isotretinoin. J Dermatol Treat 1991;1: 285-8.